lippard glutathione cisplatin A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer New drug candidate shows promise
New drug candidate shows promise against cancer MIT News Massachusetts Institute of Technology Bucillamine prevents cisplatin induced ototoxicity through induction of glutathione and antioxidant genes Experimental & Molecular Medicine Cisplatin based combination therapy for cancer : Journal of Cancer Research and Therapeutics Understanding Cisplatin Pharmacokinetics and Toxicodynamics to Predict and Prevent Kidney Injury PMC
Pay in 4 interest-free payments of $5.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21


